tiprankstipranks
Trending News
More News >
Advertisement

BFOR - ETF AI Analysis

Compare

Top Page

BFOR

ALPS Barron's 400 ETF (BFOR)

Rating:73Outperform
Price Target:
The ALPS Barron's 400 ETF (BFOR) demonstrates solid overall quality, driven by strong contributions from holdings like Globus Medical (GMED) and Regeneron (REGN). Globus Medical benefits from strategic growth initiatives and successful acquisitions, while Regeneron excels in financial health and R&D investments, positioning it well for future growth. However, risks such as overbought conditions in some holdings and challenges in specific sectors, like trade restrictions affecting Applied Materials (AMAT), may slightly temper the fund's rating.
Positive Factors
Strong Top Holdings
Several top positions, such as Idaho Strategic Resources and Stoke Therapeutics, have delivered strong year-to-date performance, supporting the ETF's overall returns.
Sector Diversification
The ETF is spread across multiple sectors, including Financials, Technology, and Industrials, which helps reduce risk from a downturn in any single industry.
Healthy Year-to-Date Performance
The fund has shown solid year-to-date performance, indicating resilience in its holdings despite short-term fluctuations.
Negative Factors
High Geographic Concentration
The ETF is heavily focused on U.S. companies, with minimal exposure to international markets, limiting global diversification.
Short-Term Underperformance
The fund has experienced a decline in one-month performance, which could signal short-term volatility or market sensitivity.
Moderate Expense Ratio
The ETF's expense ratio is higher than some low-cost alternatives, which could slightly reduce long-term returns for investors.

BFOR vs. SPDR S&P 500 ETF (SPY)

BFOR Summary

The ALPS Barron's 400 ETF (BFOR) is an investment fund that follows the Barron's 400 Index, which selects 400 companies with strong growth potential, solid financials, and good management practices. It includes a mix of industries like technology, healthcare, and financials, offering exposure to the broader U.S. market. Some well-known companies in this ETF are Micron Technology and Applied Materials. Investors might consider BFOR for diversification and the chance to invest in high-quality companies across various sectors. However, since it tracks the overall market, its value can rise and fall with market trends, making it sensitive to economic changes.
How much will it cost me?The ALPS Barron's 400 ETF (BFOR) has an expense ratio of 0.65%, meaning you’ll pay $6.50 per year for every $1,000 invested. This is higher than average because it’s actively managed, which involves more research and selection compared to passively managed ETFs that track broad indexes.
What would affect this ETF?The ALPS Barron's 400 ETF (BFOR), with its focus on U.S. companies across diverse sectors like financials, technology, and industrials, could benefit from economic growth, technological innovation, and increased consumer spending. However, it may face challenges from rising interest rates, regulatory changes, or sector-specific downturns, particularly in financials and technology. Its broad exposure to the U.S. market makes it sensitive to overall economic conditions and policy shifts.

BFOR Top 10 Holdings

The ALPS Barron's 400 ETF leans heavily into financials and technology, with notable contributions from names like Western Digital and Eli Lilly. Western Digital is rising on strong AI-driven market positioning, while Eli Lilly’s robust pipeline advancements keep it steady despite valuation concerns. Meanwhile, Tetra Technologies is lagging, weighed down by cash flow challenges and market conditions. The fund’s U.S.-centric focus and balanced sector exposure provide resilience, though its tilt toward industrials and healthcare suggests a thematic preference for innovation and infrastructure. Overall, the ETF’s diverse holdings aim to capture growth across key market drivers.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Argan0.43%$774.99K$5.46B153.43%
75
Outperform
Western Digital0.41%$754.26K$55.84B123.77%
79
Outperform
Tetra Technologies0.41%$740.68K$1.04B101.82%
77
Outperform
Globus Medical0.38%$698.55K$12.25B6.34%
82
Outperform
Applied Materials0.37%$678.55K$200.95B44.38%
77
Outperform
Micron0.37%$678.22K$266.12B141.43%
77
Outperform
Hecla Mining Company0.37%$676.62K$11.27B204.71%
75
Outperform
Eli Lilly & Co0.35%$637.75K$1.02T35.22%
71
Outperform
Dycom0.35%$632.68K$10.47B99.56%
79
Outperform
Regeneron0.35%$631.17K$82.00B3.99%
78
Outperform

BFOR Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
80.42
Positive
100DMA
79.87
Positive
200DMA
75.87
Positive
Market Momentum
MACD
0.06
Negative
RSI
59.69
Neutral
STOCH
93.50
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BFOR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 79.77, equal to the 50-day MA of 80.42, and equal to the 200-day MA of 75.87, indicating a bullish trend. The MACD of 0.06 indicates Negative momentum. The RSI at 59.69 is Neutral, neither overbought nor oversold. The STOCH value of 93.50 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BFOR.

BFOR Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$181.45M0.65%
$882.00M0.59%
$856.80M0.60%
$781.14M0.49%
$746.41M0.52%
$736.74M0.27%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BFOR
ALPS Barron's 400 ETF
81.82
3.32
4.23%
SYLD
Cambria Shareholder Yield ETF
PLDR
Putnam Sustainable Leaders ETF
ABFL
Fcf Us Quality Etf
PFM
Invesco Dividend Achievers ETF
AUSF
Global X Adaptive U.S. Factor ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement